No abstract

Lung cancer is the leading cause of human cancer mortality due to the lack of early diagnosis technology. The low-dose computed tomography scan (LDCT) is one of the main techniques to screen cancers. However, LDCT still has a risk of radiation exposure and it is not suitable for the general public. In this study, plasma metabolic profiles of lung cancer were performed using a comprehensive metabolomic method with different liquid chromatography methods coupled with a Q-Exactive high-resolution mass spectrometer. Metabolites with different polarities (amino acids, fatty acids, and acylcarnitines) can be detected and identified as differential metabolites of lung cancer in small volumes of plasma. Logistic regression models were further developed to identify cancer stages and types using those significant biomarkers. Using the Variable Importance in Projection (VIP) and the area under the curve (AUC) scores, we have successfully identified the top 5, 10, and 20 metabolites that can be used to differentiate lung cancer stages and types. The discrimination accuracy and AUC score can be as high as 0.829 and 0.869 using the five most significant metabolites. This study demonstrated that using 5 + metabolites (Palmitic acid, Heptadecanoic acid, 4-Oxoproline, Tridecanoic acid, Ornithine, and etc.) has the potential for early lung cancer screening. This finding is useful for transferring the diagnostic technology onto a point-of-care device for lung cancer diagnosis and prognosis.

Alzheimer’s dementia (AD) is a chronic neurodegenerative illness that manifests in a gradual decline of cognitive function. Early identification of AD is essential for managing the ensuing cognitive deficits, which may lead to a better prognostic outcome. Speech data can serve as a window into cognitive functioning and can be used to screen for early signs of AD. This paper describes methods for learning models using speech samples from the DementiaBank database, for identifying which subjects have Alzheimer’s dementia. We consider two machine learning tasks: 1) binary classification to distinguish patients from healthy controls, and 2) regression to estimate each subject’s Mini-Mental State Examination (MMSE) score. To develop models that can use acoustic and/or language features, we explore a variety of dimension reduction techniques, training algorithms, and fusion strategies. Our best performing classification model, using language features with dimension reduction and regularized logistic regression, achieves an accuracy of 85.4% on a held-out test set. On the regression task, a linear regression model trained on a reduced set of language features achieves a root mean square error (RMSE) of 5.62 on the test set. These results demonstrate the promise of using machine learning for detecting cognitive decline from speech in AD patients.

No abstract